Artificial Intelligence

Comparing Four AI-Powered Drug Discovery Stocks

A technology like artificial intelligence (AI) is extraordinarily complex to begin with. When you start to apply AI to complex domains like drug discovery, there’s a snowball’s chance in hell your average retail investor will understand what’s happening under the hood. If, as risk averse investors, we adhere to Warren Buffett’s adage of only investing […]

What Does Databricks Do and Why Should Investors Care?

Nanalyze has been writing about big data since, well, it became big. While the term has been around since the 1990s, it really hit the big time about 10 years ago. It refers to extremely large and unwieldy datasets, which can be analyzed to reveal patterns or trends, often related to human behavior. Big data […]

5 Private Enterprise AI Companies to Watch

While much of our attention has been focused on the seemingly never-ending bull market – pandemic and economic reality be damned – it’s hard not to notice just how much money is being poured into the private market. Global funding to startups in the second quarter of this year was $156 billion. That’s just three […]

HeartFlow Stock: Using AI to Combat Heart Disease

The older you get, the more you start to understand why old people spend so much time talking about their health problems. It usually starts in your mid-40s when you realize you’re at the age where you should get regular health screens. You go in for bloodwork, and the doctor says you have high cholesterol. […]

Why Veritone Stock Is An AI Company We’re Avoiding

Warren Buffet famously said to invest only in what you know, something that especially rings true in today’s world of ICOs and NFTs. No matter how complex a technology is, the purveyor should be able to explain it simply. The inability to clearly articulate a value proposition is a big red flag, and one company […]

Alteryx Stock is Dropping, But No Need to Worry

Even seasoned investors confuse stock price movements with the quality of the underlying business. We may say to avoid a stock because we don’t believe the business model is economically viable. When the stock doubles the next day because some chump on Reddit decided to manipulate it, people are quick to say “see, you were […]

7 Synthetic Data Companies for Training AI Models

Last year, we opted to exit our position in Appen (APX.AX), an Australian company whose core business involves annotating and labeling training data for AI models. It turned out to be a good decision: Appen has lost nearly -70% in the last year, compared to +38% for the NASDAQ during that time. Our main argument […]

Why We’re Selling NVIDIA Shares After the Split

Don’t study finance if you’re the sort of person who detests boredom. Some of the topics are absolutely dreadful, not to mention the teachers. They’ll make you do things like manually calculate the variance of a portfolio, something that sounds about as fun as it looks. If you’re a glutton for punishment, do a Master’s […]

NICE Stock: Contact Centers as a Service

Just prior to the dot bomb era, evidence was emerging that customer service functions were being offshored. What started with John in Mumbai ended up with Rosie in Manila. Cheaper office space and labor, a greater propensity to please, and a greater degree of “accent neutralization” were all factors in the migration of customer call […]

Sema4 Stock – AI-Powered Precision Medicine

If you like buying special purpose acquisition companies (SPACs) at $10 a share, you’ll love buying them at $6.67 a share. A Sober Look at SPACs was a study last year by Stanford and NYU that revealed “by the time the median SPAC merges with a target, it holds just $6.67 in cash for each […]